Can Drug Effects Explain the Recent Temporal Increase in Atonic Postpartum Haemorrhage?

Paediatric and Perinatal Epidemiology

Volumn 29, Issue 3, 2015, Pages 220-231

  Joseph, K S ^a   Sheehy, Odile ^b   Mehrabadi, Azar ^a   Urquia, Marcelo L ^c   Hutcheon, Jennifer A ^a   Kramer, Michael ^d   Bérard, Anick ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Atonic postpartum hemorrhage; etiology; selective serotonin reuptake inhibitors; temporal trends; thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DOXYLAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ANXIETY DISORDERS; ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED; COMORBIDITY; CONTROLLED STUDY; DRUG USE; DYSTOCIA; FEMALE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; NEWBORN; PATHOPHYSIOLOGY; POSTPARTUM HEMORRHAGE; PREGNANCY; QUEBEC; STATISTICAL MODEL; TEMPORAL ANALYSIS; THROMBOCYTOPENIA; UTERINE ATONY;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; PLATELET AGGREGATION INHIBITORS; POSTPARTUM HEMORRHAGE; PREGNANCY; QUEBEC; SEROTONIN UPTAKE INHIBITORS; UTERINE INERTIA;

EID: 85007190254     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/ppe.12190     Document Type: Article

References (40)

1. Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA. Increased postpartum hemorrhage rates in Australia. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 2007; 98:237–243.
2. Joseph KS, Rouleau J, Kramer MS, Young DC, Liston RM, Baskett TF. Investigation of an increase in postpartum haemorrhage in Canada. BJOG: An International Journal of Obstetrics and Gynaecology 2007; 114:751–759.
3. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy and Childbirth 2009; 9:55.
4. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994–2006. American Journal of Obstetrics and Gynecology 2010; 202:353, e351–e356.
5. Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesthesia and Analgesia 2010; 110:1368–1373.
6. Rossen J, Økland I, Bjarte Nilsen O, Eggebø TM. Is there an increase of postpartum hemorrhage, and is severe hemorrhage associated with more frequent use of obstetric interventions? Obstetrical and Gynecological Survey 2011; 66:18–20.
7. Lutomski JE, Byrne BM, Devane D, Greene RA. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG: An International Journal of Obstetrics and Gynaecology 2012; 119:306–314.
8. NHS Scotland. Scottish Confidential Audit of Severe Maternal Morbidity (7th Annual Report) 2011. http://www.scottishpatientsafetyprogramme.scot.nhs.uk/Media/Docs/MCQIC/Maternity%20Care/2013-08-09%20Final%209th%20annual%20SCASMM%20report.pdf [last accessed March 27, 2015].
9. Mehrabadi A, Hutcheon JA, Lee L, Kramer MS, Liston RM, Joseph KS. Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: a population-based retrospective cohort study. BJOG: An International Journal of Obstetrics and Gynaecology 2013; 120:853–862.
10. Kramer MS, Berg C, Abenhaim H, Dahhou M, Rouleau J, Mehrabadi A, et al. Incidence, risk factors, and temporal trends in severe postpartum hemorrhage. American Journal of Obstetrics and Gynecology 2013; 209:449.e1–449.e7.
11. Mehrabadi A, Liu S, Bartholomew S, Hutcheon JA, Kramer MS, Liston RM, et al. Temporal trends in postpartum hemorrhage and severe postpartum hemorrhage in Canada from 2003 to 2010. Journal of Obstetrics and Gynaecology Canada 2014; 36:21–33.
12. Blomberg M. Maternal obesity and risk of postpartum hemorrhage. Obstetrics and Gynecology 2011; 118:561–568.
13. Grotegut CA, Paglia MJ, Johnson LN, Thames B, James AH. Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony. American Journal of Obstetrics and Gynecology 2011; 204:e51–e56.
14. Kramer MS, Dahhou M, Vallerand D, Liston R, Joseph KS. Risk factors for postpartum hemorrhage: can we explain the recent temporal increase? Journal of Obstetrics and Gynaecology Canada 2011; 33:810–819.
15. Cooper WO, Willy ME, Pont SJ, Ray WA. Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology 2007; 196:544.e1–544.e5.
16. Wichman CL, Fothergill A, Moore KM, Lang TR, Heise RH Jr, Watson WJ. Recent trends in selective serotonin reuptake inhibitor use in pregnancy. Journal of Clinical Psychopharmacology 2008; 28:714–716.
17. Thorpe PG, Gilboa SM, Hernandez-Diaz S, Lind J, Cragan JD, Briggs G, et al. Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiology and Drug Safety 2013; 22:1013–1018.
18. Golding J. A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. British Journal of Obstetrics and Gynaecology 1998; 105:293–299.
19. Palmsten K, Hernández-Díaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED, et al. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ (Clinical Research Ed.) 2013; 347:f4877.
20. Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ: Canadian Medical Association Journal 2011; 183:1835–1843.
21. Löppönen P, Tetri S, Juvela S, Huhtakangas J, Saloheimo P, Bode MK, et al. Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: a population-based study. Journal of Neurosurgery 2014; 120:1358–1363.
22. Bérard A, Sheehy O. The Quebec Pregnancy Cohort – prevalence of medication use during gestation and pregnancy outcomes. PLoS ONE 2014; 9:e93870.
23. Bérard A, Lacasse A. Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database. The Canadian Journal of Clinical Pharmacology 2009; 16:360–369.
24. Vilain A, Otis S, Forget A, Blais L. Agreement between administrative databases and medical charts for pregnancy-related variables among asthmatic women. Pharmacoepidemiology and Drug Safety 2008; 17:345–353.
25. Miettinen OS. The clinical trial as a paradigm for epidemiologic research. Journal of Clinical Epidemiology 1989; 42:491–496, discussion 497–8.
26. Miettinen OS. The ‘case–control’ study: valid selection of subjects. Journal of Chronic Diseases 1985; 38:543–548.
27. Miettinen O. Estimability and estimation in case–referent studies. American Journal of Epidemiology 1976; 103:226–235.
28. Rothman KJ, Greenland S, Lash TL (eds). Modern Epidemiology, 3rd edn. New York: Lippincott Williams & Wilkins, 2008; pp. 113–114.
29. Breslow NE, Day NE. Statistical Methods in Cancer Research: Vol. I – The Analysis of Case–Control Studies. Lyon: IARC, 1980. Scientific Publ. No 32.
30. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. American Journal of Public Health 1998; 88:15–19.
31. Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. The Journal of Clinical Psychiatry 2010; 71:1565–1575.
32. de Abajo FJ. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs and Aging 2011; 28:345–367.
33. Salkeld E, Ferris LE, Juurlink DN. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. Journal of Clinical Psychopharmacology 2008; 28:230–234.
34. Alwan S, Friedman JM. Safety of selective serotonin reuptake inhibitors in pregnancy. CNS Drugs 2009; 23:493–509.
35. Alexander S, Dodds L, Armson BA. Perinatal outcomes in women with asthma during pregnancy. Obstetrics and Gynecology 1998; 92:435–440.
36. Tan KS, Thomson NC. Asthma in pregnancy. The American Journal of Medicine 2000; 109:727–733.
37. Wen SW, Demissie K, Liu S. Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population. Annals of Epidemiology 2001; 11:7–12.
38. Tata LJ, Lewis SA, McKeever TM, Smith CJ, Doyle P, Smeeth L, et al. A comprehensive analysis of adverse obstetric and pediatric complications in women with asthma. American Journal of Respiratory and Critical Care Medicine 2007; 175:991–997.
39. Sibai BM, Caritis SN, Thom E, Shaw K, McNellis D. Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. American Journal of Obstetrics and Gynecology 1995; 172:1553–1557.
40. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews 2007; (2):CD004659.